CD200: a putative therapeutic target in cancer
CD200 was recently described as a new prognosis factor in multiple myeloma and acute
myeloid leukemia. CD200 is a membrane glycoprotein that imparts an immunoregulatory …
myeloid leukemia. CD200 is a membrane glycoprotein that imparts an immunoregulatory …
CD200: a putative therapeutic target in cancer.
J Moreaux, JL Veyrune, T Rème… - Biochemical and …, 2008 - inserm.hal.science
CD200 was recently described as a new prognosis factor in multiple myeloma and acute
myeloid leukemia. CD200 is a membrane glycoprotein that imparts an immunoregulatory …
myeloid leukemia. CD200 is a membrane glycoprotein that imparts an immunoregulatory …
[引用][C] CD200: A putative therapeutic target in cancer
J Moreaux, JL Veyrune, T Reme, J De Vos… - Biochemical and …, 2008 - cir.nii.ac.jp
CD200: A putative therapeutic target in cancer | CiNii Research CiNii 国立情報学研究所 学術
情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …
情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …
CD200: a putative therapeutic target in cancer.
J Moreaux, JL Veyrune, T Reme, J De Vos… - Biochemical and …, 2007 - europepmc.org
CD200 was recently described as a new prognosis factor in multiple myeloma and acute
myeloid leukemia. CD200 is a membrane glycoprotein that imparts an immunoregulatory …
myeloid leukemia. CD200 is a membrane glycoprotein that imparts an immunoregulatory …
CD200: A putative therapeutic target in cancer
J Moreaux, JL Veyrune, T Reme, J De Vos… - Biochemical and …, 2008 - infona.pl
CD200 was recently described as a new prognosis factor in multiple myeloma and acute
myeloid leukemia. CD200 is a membrane glycoprotein that imparts an immunoregulatory …
myeloid leukemia. CD200 is a membrane glycoprotein that imparts an immunoregulatory …
CD200: a putative therapeutic target in cancer
J Moreaux, JL Veyrune, T Reme… - Biochemical and …, 2008 - pubmed.ncbi.nlm.nih.gov
CD200 was recently described as a new prognosis factor in multiple myeloma and acute
myeloid leukemia. CD200 is a membrane glycoprotein that imparts an immunoregulatory …
myeloid leukemia. CD200 is a membrane glycoprotein that imparts an immunoregulatory …
CD200: a putative therapeutic target in cancer.
J Moreaux, JL Veyrune, T Rème, J de Vos… - Biochemical and …, 2008 - hal.science
CD200 was recently described as a new prognosis factor in multiple myeloma and acute
myeloid leukemia. CD200 is a membrane glycoprotein that imparts an immunoregulatory …
myeloid leukemia. CD200 is a membrane glycoprotein that imparts an immunoregulatory …